rs7804372

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001753.5(CAV1):​c.196-4772T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.265 in 152,110 control chromosomes in the GnomAD database, including 5,465 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.26 ( 5465 hom., cov: 32)

Consequence

CAV1
NM_001753.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.574

Publications

46 publications found
Variant links:
Genes affected
CAV1 (HGNC:1527): (caveolin 1) The scaffolding protein encoded by this gene is the main component of the caveolae plasma membranes found in most cell types. The protein links integrin subunits to the tyrosine kinase FYN, an initiating step in coupling integrins to the Ras-ERK pathway and promoting cell cycle progression. The gene is a tumor suppressor gene candidate and a negative regulator of the Ras-p42/44 mitogen-activated kinase cascade. Caveolin 1 and caveolin 2 are located next to each other on chromosome 7 and express colocalizing proteins that form a stable hetero-oligomeric complex. Mutations in this gene have been associated with Berardinelli-Seip congenital lipodystrophy. Alternatively spliced transcripts encode alpha and beta isoforms of caveolin 1.[provided by RefSeq, Mar 2010]
CAV1 Gene-Disease associations (from GenCC):
  • pulmonary arterial hypertension
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • pulmonary hypertension, primary, 3
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • congenital generalized lipodystrophy type 3
    Inheritance: AD, AR Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, G2P
  • heritable pulmonary arterial hypertension
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Berardinelli-Seip congenital lipodystrophy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.314 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001753.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CAV1
NM_001753.5
MANE Select
c.196-4772T>A
intron
N/ANP_001744.2
CAV1
NM_001172895.1
c.103-4772T>A
intron
N/ANP_001166366.1
CAV1
NM_001172896.2
c.103-4772T>A
intron
N/ANP_001166367.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CAV1
ENST00000341049.7
TSL:1 MANE Select
c.196-4772T>A
intron
N/AENSP00000339191.2
CAV1
ENST00000393467.1
TSL:1
c.103-4772T>A
intron
N/AENSP00000377110.1
CAV1
ENST00000393468.1
TSL:1
c.103-4772T>A
intron
N/AENSP00000377111.1

Frequencies

GnomAD3 genomes
AF:
0.264
AC:
40201
AN:
151992
Hom.:
5462
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.319
Gnomad AMI
AF:
0.279
Gnomad AMR
AF:
0.224
Gnomad ASJ
AF:
0.250
Gnomad EAS
AF:
0.219
Gnomad SAS
AF:
0.261
Gnomad FIN
AF:
0.278
Gnomad MID
AF:
0.248
Gnomad NFE
AF:
0.243
Gnomad OTH
AF:
0.259
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.265
AC:
40237
AN:
152110
Hom.:
5465
Cov.:
32
AF XY:
0.264
AC XY:
19615
AN XY:
74370
show subpopulations
African (AFR)
AF:
0.319
AC:
13229
AN:
41468
American (AMR)
AF:
0.224
AC:
3420
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.250
AC:
865
AN:
3466
East Asian (EAS)
AF:
0.220
AC:
1138
AN:
5182
South Asian (SAS)
AF:
0.260
AC:
1253
AN:
4822
European-Finnish (FIN)
AF:
0.278
AC:
2939
AN:
10582
Middle Eastern (MID)
AF:
0.253
AC:
74
AN:
292
European-Non Finnish (NFE)
AF:
0.243
AC:
16523
AN:
67988
Other (OTH)
AF:
0.257
AC:
542
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1516
3031
4547
6062
7578
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
414
828
1242
1656
2070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.246
Hom.:
604
Bravo
AF:
0.264
Asia WGS
AF:
0.214
AC:
750
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
12
DANN
Benign
0.83
PhyloP100
0.57
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7804372; hg19: chr7-116194228; API